Hypertrophic And Keloid Scar Treatment Global Market Report 2024

Description

“Hypertrophic And Keloid Scar Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hypertrophic and keloid scar treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hypertrophic and keloid scar treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The hypertrophic and keloid scar treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Treatment: Cryotherapy; Surgical Excision; Pressure Dressings; Intralesional 5-Fluorouracil; Superficial X-Ray; Intralesional Corticosteroid Injection; Other Treatments
2) By Products: Topical Products; Laser Products; Injectables; Other Products
3) By Scar: Hypertrophic Scars; Keloid Scars
4) By End-Use: Hospitals; Clinics; Other End-Users
Companies Mentioned: Smith & Nephew plc; Merz Pharmaceutical LLC; Lumenis Ltd.; Enaltus LLC; Sonoma Pharmaceuticals Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Hypertrophic and keloid scar treatment involves addressing scars that either remain within the boundaries of the original wound (hypertrophic) or extend beyond those boundaries and do not regress (keloids). Hypertrophic scars are contained within the area of the initial injury, while keloids spread outside the boundaries of the initial damage.

The main treatments for hypertrophic and keloid scars include cryotherapy, surgical excision, pressure dressings, intralesional 5-fluorouracil, superficial X-ray, intralesional corticosteroid injection, and others. Cryotherapy is a medical procedure that uses extremely cold liquid or a cryoprobe to freeze and destroy abnormal tissue. It is employed to destroy the core of keloid scars while preserving surface-level cells and tissues. Various products, including topical products, laser products, injectables, and others, are used during treatment. The end-users of hypertrophic and keloid scar treatment include hospitals, clinics, and other healthcare facilities.

The hypertrophic and keloid scar treatment market research report is one of a series of new reports from The Business Research Company that provides hypertrophic and keloid scar treatment market statistics, including hypertrophic and keloid scar treatment industry global market size, regional shares, competitors with a hypertrophic and keloid scar treatment market share, detailed hypertrophic and keloid scar treatment market segments, market trends and opportunities, and any further data you may need to thrive in the hypertrophic and keloid scar treatment industry. This hypertrophic and keloid scar treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hypertrophic and keloid scar treatment market size has grown rapidly in recent years. It will grow from $6.91 billion in 2023 to $7.67 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The expansion observed during the historical period can be attributed to factors such as the increased incidence of hypertrophic and keloid scars, advancements in scar assessment techniques, widespread adoption of topical treatments, surgical and invasive procedures, and growing patient demand for scar improvement.

The hypertrophic and keloid scar treatment market size is expected to see strong growth in the next few years. It will grow to $11.14 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The anticipated growth in the forecast period can be attributed to emerging minimally invasive interventions, advancements in scar revision techniques, a growing interest in combination therapies, increasing awareness and early intervention, and global aesthetic trends. Major trends expected in the forecast period include the emergence of injectable therapies for scar treatment, the use of combination therapies for synergistic effects, patient-centric approaches to scar management, the development of scar assessment technologies, and the utilization of telemedicine for follow-up and consultations in the field of hypertrophic and keloid scar treatment.

The hypertrophic and keloid scar treatment market is anticipated to witness growth due to an increase in the number of road accidents and burn cases. Road accidents involving at least one vehicle and individuals necessitate attention and effective treatment to address resulting scars. Hypertrophic and keloid scar treatments play a crucial role in lowering the height and tightness of scars, contributing to the market's expansion. For instance, statistics from the National Highway Traffic Safety Administration in August 2022 revealed a nearly 7% increase in motor vehicle traffic accident fatalities during the first three months of 2022 compared to the same period in 2021, highlighting the need for scar treatments in such cases.

The market for hypertrophic and keloid scar treatment is also expected to grow with the increasing prevalence of aesthetic procedures. Aesthetic procedures, which aim to enhance appearance through non-invasive or minimally invasive cosmetic treatments, often incorporate scar treatment to improve the outcome aesthetically. The hypertrophic and keloid scar treatment market benefits from this trend, contributing to a smoother and more pleasing appearance. The Aesthetic Society reported a significant 54% rise in US plastic surgical procedures in 2021, indicating a growing demand for aesthetic interventions.

Leading companies in the hypertrophic and keloid scar treatment market are strategically focusing on the development of clinically proven solutions, particularly those based on silicone, such as medical-grade silicone strips. These therapeutic products made from high-quality silicone are formulated to promote scar healing and reduction, offering an effective solution for various scar types. An example is Scar Erase, a UK-based company, which launched clinically tested silicone strips designed for scar healing and reduction, catering to hypertrophic, keloid, post-surgery, and stretch mark scars.

Major players in the market are also investing in advanced dermatological lines that leverage innovative technologies such as Microcyn technology. This technology accelerates wound healing, combats infections, and alleviates symptoms, providing clinically proven solutions. Sonoma Pharmaceuticals, a US-based pharmaceutical company, introduced a line of office dispensed products, including Regenacyn Plus, which is clinically proven to enhance the appearance of keloid and hypertrophic scars, offering relief from itch and pain while reducing infection risk.

In July 2022, Sinclair Pharma, a UK-based aesthetics company, completed the acquisition of Viora Ltd. The financial details of the acquisition remain undisclosed. This strategic move is expected to grant Sinclair access to Viora's portfolio of non-invasive and minimally invasive aesthetic devices. Additionally, the acquisition is anticipated to facilitate Sinclair's entry into the US market on a commercial scale. Viora Ltd., based in the US, specializes in providing medical aesthetic devices and solutions, including offerings related to scar and stretch mark revision, acne clearance, and various other aesthetic treatments.

Major companies operating in the hypertrophic and keloid scar treatment market report are Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Mylan N.V., Stratpharma AG, Revitol Corporation Inc., Quantum Health, Scarfade, Biodermis, Renovo Group plc, Mederma, Silagen

North America was the largest region in the hypertrophic and keloid scar treatment market in 2023. Asia-pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hypertrophic and keloid scar treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hypertrophic and keloid scar treatment market consist of revenues earned by entities by providing occlusive dressings, compression therapy, intralesional corticosteroid injections, cryosurgery, excision, radiation therapy, laser therapy, interferon (IFN) therapy, doxorubicin, bleomycin, and verapamil. The market value includes the value of related goods sold by the service provider or included within the service offering. The hypertrophic and keloid scar treatment market also includes sales of skin camouflage, silicon gels, and skin needling. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11809

1. Executive Summary

2. Hypertrophic And Keloid Scar Market Characteristics

3. Hypertrophic And Keloid Scar Market Trends And Strategies

4. Hypertrophic And Keloid Scar Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Hypertrophic And Keloid Scar Market Size and Growth

5.1. Global Hypertrophic And Keloid Scar Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Hypertrophic And Keloid Scar Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Hypertrophic And Keloid Scar Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hypertrophic And Keloid Scar Market Segmentation

6.1. Global Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cryotherapy
Surgical Excision
Pressure Dressings
Intralesional 5-Fluorouracil
Superficial X-Ray
Intralesional Corticosteroid Injection
Other Treatments
6.2. Global Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Topical Products
Laser Products
Injectables
Other Products
6.3. Global Hypertrophic And Keloid Scar Market, Segmentation By Scar, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hypertrophic Scars
Keloid Scars
6.4. Global Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Clinics
Other End-Users

7. Hypertrophic And Keloid Scar Market Regional And Country Analysis

7.1. Global Hypertrophic And Keloid Scar Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Hypertrophic And Keloid Scar Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hypertrophic And Keloid Scar Market

8.1. Asia-Pacific Hypertrophic And Keloid Scar Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hypertrophic And Keloid Scar Market

9.1. China Hypertrophic And Keloid Scar Market Overview
9.2. China Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hypertrophic And Keloid Scar Market

10.1. India Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hypertrophic And Keloid Scar Market

11.1. Japan Hypertrophic And Keloid Scar Market Overview
11.2. Japan Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hypertrophic And Keloid Scar Market

12.1. Australia Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hypertrophic And Keloid Scar Market

13.1. Indonesia Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hypertrophic And Keloid Scar Market

14.1. South Korea Hypertrophic And Keloid Scar Market Overview
14.2. South Korea Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hypertrophic And Keloid Scar Market

15.1. Western Europe Hypertrophic And Keloid Scar Market Overview
15.2. Western Europe Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hypertrophic And Keloid Scar Market

16.1. UK Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hypertrophic And Keloid Scar Market

17.1. Germany Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hypertrophic And Keloid Scar Market

18.1. France Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hypertrophic And Keloid Scar Market

19.1. Italy Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hypertrophic And Keloid Scar Market

20.1. Spain Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hypertrophic And Keloid Scar Market

21.1. Eastern Europe Hypertrophic And Keloid Scar Market Overview
21.2. Eastern Europe Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hypertrophic And Keloid Scar Market

22.1. Russia Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hypertrophic And Keloid Scar Market

23.1. North America Hypertrophic And Keloid Scar Market Overview
23.2. North America Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hypertrophic And Keloid Scar Market

24.1. USA Hypertrophic And Keloid Scar Market Overview
24.2. USA Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hypertrophic And Keloid Scar Market

25.1. Canada Hypertrophic And Keloid Scar Market Overview
25.2. Canada Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hypertrophic And Keloid Scar Market

26.1. South America Hypertrophic And Keloid Scar Market Overview
26.2. South America Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hypertrophic And Keloid Scar Market

27.1. Brazil Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hypertrophic And Keloid Scar Market

28.1. Middle East Hypertrophic And Keloid Scar Market Overview
28.2. Middle East Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hypertrophic And Keloid Scar Market

29.1. Africa Hypertrophic And Keloid Scar Market Overview
29.2. Africa Hypertrophic And Keloid Scar Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Hypertrophic And Keloid Scar Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Hypertrophic And Keloid Scar Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hypertrophic And Keloid Scar Market Competitive Landscape And Company Profiles

30.1. Hypertrophic And Keloid Scar Market Competitive Landscape
30.2. Hypertrophic And Keloid Scar Market Company Profiles
- 30.2.1. Smith & Nephew plc
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Merz Pharmaceutical LLC
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Lumenis Ltd.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Enaltus LLC
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Sonoma Pharmaceuticals Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Hypertrophic And Keloid Scar Market Competitive Benchmarking

32. Global Hypertrophic And Keloid Scar Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Hypertrophic And Keloid Scar Market

34. Hypertrophic And Keloid Scar Market Future Outlook and Potential Analysis

34.1 Hypertrophic And Keloid Scar Market In 2028 - Countries Offering Most New Opportunities
34.2 Hypertrophic And Keloid Scar Market In 2028 - Segments Offering Most New Opportunities
34.3 Hypertrophic And Keloid Scar Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer